Human ENT1 is predictive of response in patients with pancreatic cancer treated with gemcitabine: Results from the RTOG 9704 prospective randomized trial

被引：5

作者：

Farrell, J. ^{[1
]}

Garcia, M. ^{[2
]}

Lai, R. ^{[3
]}

Ammar, A. ^{[1
]}

Regine, W. ^{[4
]}

Abrams, R. ^{[5
]}

Benson, A. Bowen ^{[6
]}

Macdonald, J. ^{[7
]}

Cass, C. E. ^{[3
]}

Elsaleh, H. ^{[8
]}

Mackey, J. ^{[3
]}

机构：

[1] Univ Calif Los Angeles, Sch Med, Div Digest Dis, Los Angeles, CA USA

[2] RTOG, Philadelphia, PA USA

[3] Univ Alberta, Cross Canc Ctr, Edmonton, AB, Canada

[4] Univ Maryland Med Syst, Baltimore, MD USA

[5] Rush Univ, Med Ctr, Chicago, IL 60612 USA

[6] Northwestern Univ, Chicago, IL 60611 USA

[7] St Vincents CCC, New York, NY USA

[8] Australian Natl Univ, Canberra, ACT, Australia

来源：

关键词：

D O I：

10.1097/01.mpa.0000297698.99488.6c

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：401 / 402

页数：2